心脏骤停后低氧性ICU患者的较低与较高氧合目标比较
该研究为HOT-ICU试验的亚组分析,纳入心脏骤停后入ICU的成人低氧性呼吸衰竭患者335例,随机分入动脉氧合目标8 kPa组(149例)或12 kPa组(186例),干预最长90天。90天时低氧合组死亡96/147例(65.3%),高氧合组死亡111/185例(60.0%),校正RR 1.09(95%CI 0.92-1.28,p=0.32);1年时校正RR 1.05(95%CI 0.90-1.21,p=0.53)。ICU内严重不良事件低氧合组23% vs 高氧合组38%,校正RR 0.61(95%CI 0.43-0.86,p=0.005),差异主要因高氧合组新发休克 episodes 更多。结论:较低氧合目标未降低死亡率,但严重不良事件更少,所有分析为探索性,需大规模试验确认。
要点
- 心脏骤停后低氧性呼吸衰竭的成人ICU患者,较低氧合目标(8 kPa)与较高目标(12 kPa)相比,90天死亡率无显著差异(65.3% vs 60.0%,校正RR 1.09,95%CI 0.92-1.28,p=0.32)。
- 1年死亡率同样无显著差异(校正RR 1.05,95%CI 0.90-1.21,p=0.53)。
- ICU内严重不良事件较低氧合组23% vs 高氧合组38%(校正RR 0.61,95%CI 0.43-0.86,p=0.005),差异主要因高氧合组新发休克更多。
- 其他次要结局无统计学显著差异。
- 所有分析仅为探索性,需大规模试验确认。
适用人群与场景
- 成人ICU患者,心脏骤停后出现低氧性呼吸衰竭,纳入HOT-ICU试验亚组。
诊断标准与关键阈值
- 动脉氧合目标:较低氧合组8 kPa,较高氧合组12 kPa,在ICU内实施最长90天。
处置流程与药物剂量
- 较低氧合组:动脉氧合目标8 kPa,在ICU内实施最长90天。
- 较高氧合组:动脉氧合目标12 kPa,在ICU内实施最长90天。
研究设计与关键结果
- 研究类型:国际HOT-ICU随机对照试验的亚组分析,纳入心脏骤停后患者335例(较低氧合组149例,较高氧合组186例)。
- 90天死亡率:较低氧合组96/147例(65.3%) vs 较高氧合组111/185例(60.0%),校正RR 1.09(95%CI 0.92-1.28,p=0.32)。
- 1年死亡率:校正RR 1.05(95%CI 0.90-1.21,p=0.53)。
- ICU内严重不良事件:较低氧合组23% vs 较高氧合组38%,校正RR 0.61(95%CI 0.43-0.86,p=0.005),差异主要因较高氧合组新发休克 episodes 更多。
- 其他次要结局无统计学显著差异。
证据类型、等级与局限
- 证据类型:随机对照试验(HOT-ICU)的亚组分析;所有分析为探索性。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于心脏骤停后低氧性呼吸衰竭的成人ICU患者,较低氧合目标(8 kPa)未降低死亡率,但严重不良事件更少;所有分析仅为探索性,需大规模试验确认。
指南或共识出处
- HOT-ICU试验(Clinicaltrials.gov NCT03174002,注册于2017年5月30日;EudraCT 2017-000632-34,注册于2017年2月14日)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: To investigate the effects of lower versus higher oxygenation targets in adult intensive care unit (ICU) patients with hypoxaemic respiratory failure after cardiac arrest.
METHODS: Subgroup analysis of the international Handling Oxygenation Targets in the ICU (HOT-ICU) trial which randomised 2928 adults with acute hypoxaemia to targets of arterial oxygenation of 8 kPa or 12 kPa in the ICU for up to 90 days. Here, we report all outcomes up to one year in the subgroup of patients enrolled after cardiac arrest.
RESULTS: The HOT-ICU trial included 335 patients after cardiac arrest: 149 in the lower-oxygenation group and 186 in the higher-oxygenation group. At 90 days, 96/147 patients (65.3%) in the lower-oxygenation group and 111/185 patients (60.0%) in the higher-oxygenation group had died (adjusted relative risk (RR) 1.09, 95% confidence interval (CI) 0.92-1.28, p = 0.32); similar results were found at one year (adjusted RR 1.05, 95% CI 0.90-1.21, p = 0.53). Serious adverse events (SAEs) in the ICU occurred in 23% of patients in the lower-oxygenation group and 38% in the higher-oxygenation group (adjusted RR 0.61, 95% CI 0.43-0.86, p = 0.005); the difference was mainly due to more new episodes of shock in the higher-oxygenation group. No statistically significant differences were observed in other secondary outcomes.
CONCLUSION: A lower oxygenation target in adult ICU patients with hypoxaemic respiratory failure after cardiac arrest did not result in lower mortality, but fewer SAEs occurred in this group compared to the higher-oxygenation group. All analyses are exploratory only, large-scale trials are needed for confirmation.
CLINICAL TRIAL REGISTRY: Clinicaltrials.gov number NCT03174002 (registered May 30, 2017); EudraCT 2017-000632-34 (registered February 14, 2017).
参考来源
- Crescioli E, Lass Klitgaard T, Perner A, et al. Lower versus higher oxygenation targets in hypoxaemic ICU patients after cardiac arrest. Resuscitation. 2023. PMID: 37196799. doi:10.1016/j.resuscitation.2023.109838
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。